Atopic Disease Therapeutics Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-28　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 13.9 Bn
2033 年預估規模: USD 26.24 Bn
年複合成長率 CAGR: 9.5%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 168報告編號 CMI9269

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Atopic Disease Therapeutics Market, By Disease Type (Atopic Dermatitis, Allergic Rhinitis, Asthma, Food Allergies, Conjunctivitis, and Others), By Drug Class (Topical Steroids, Topical Calcineurin Inhibitors, Biologics (e.g., Monoclonal Antibodies, JAK Inhibitors), Systemic Steroids, Immunosuppressants, and Others), By Route of Administration (Topical, Oral, and Injectable), By End User (Hospitals, Dermatology Clinics, Homecare Settings, and Pharmacies), By Distribution Channel (Online and Offline), By Patient Type (Acute and Chronic), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

According to Coherent Market Insights, the global atopic disease therapeutics market is estimated to be valued at USD 13.9 Bn in 2026 and is expected to reach USD 26.24 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033. The global atopic disease therapeutics market represents a critical segment within the pharmaceutical and biotechnology industries, addressing a spectrum of chronic inflammatory conditions characterized by heightened immune responses and skin barrier dysfunction. Atopic diseases, including atopic dermatitis, allergic asthma, allergic rhinitis, and food allergies, collectively affect millions of individuals worldwide, creating substantial healthcare burdens and significantly impacting patients' quality of life. These interconnected conditions share common pathophysiological mechanisms involving dysregulated immune responses, genetic predisposition, and environmental triggers, leading to persistent inflammation and tissue damage. The therapeutic landscape for atopic diseases has evolved considerably, transitioning from traditional symptomatic treatments to targeted biologics and advanced immunomodulatory therapies. Modern treatment approaches focus on addressing underlying inflammatory pathways, particularly those involving interleukin signaling cascades, IgE-mediated responses, and Th2 cell activation. The market encompasses various therapeutic modalities including topical corticosteroids, systemic immunosuppressants, biologics targeting specific cytokines, small molecule inhibitors, and emerging precision medicine approaches. Growing awareness of atopic disease prevalence, improved diagnostic capabilities, and increasing patient demand for effective long-term management solutions continue to drive market expansion, positioning this sector as a dynamic and rapidly evolving therapeutic area with significant commercial potential. Market Dynamics The global atopic disease therapeutics market is primarily driven by the escalating prevalence of atopic conditions worldwide, particularly in developed nations where environmental factors, lifestyle changes, and improved diagnostic awareness contribute to increased disease recognition and treatment seeking behavior. The rising incidence of atopic dermatitis, affecting approximately 15-20% of children and 1-3% of adults globally, coupled with growing allergic asthma rates exceeding 300 million cases worldwide, creates substantial market demand for effective therapeutic interventions. Technological advancements in biologics development, particularly monoclonal antibodies targeting specific inflammatory mediators such as IL-4, IL-13, IL-5, and IgE pathways, have revolutionized treatment paradigms and expanded therapeutic options for patients with moderate-to-severe atopic diseases. Additionally, increased healthcare expenditure, improved insurance coverage for specialized treatments, and growing patient advocacy for better quality of life solutions further propel market growth. However, the market faces significant restraints including the high cost of novel biologic therapies, which often exceed $30,000 annually per patient, creating accessibility barriers and limiting adoption in price-sensitive markets. Stringent regulatory requirements for drug approval, particularly for pediatric indications, result in prolonged development timelines and increased R&D costs, potentially deterring smaller pharmaceutical companies from entering the market. Safety concerns associated with long-term immunosuppressive therapy use, including increased infection risks and potential malignancy concerns, also create prescriber hesitancy and patient compliance challenges. Nevertheless, substantial opportunities exist in emerging markets where rising healthcare awareness and improving economic conditions drive demand for advanced therapeutics. The development of personalized medicine approaches utilizing biomarker identification, genetic profiling, and precision dosing strategies presents significant growth potential, while the exploration of novel therapeutic targets including barrier repair mechanisms, microbiome modulation, and innovative drug delivery systems offers promising avenues for market expansion and differentiation. Key Features of the Study • This report provides in-depth analysis of the global atopic disease therapeutics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global atopic disease therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Pfizer Inc, Sanofi, AbbVie Inc, Galderma Laboratories, L.P., Eli Lilly and Company, Regeneron Pharmaceuticals Inc, LEO Pharma Inc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, Incyte Corporation, Astellas Pharma Inc, Bayer AG, Allergan plc, Amgen Inc, and GlaxoSmithKline plc • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global atopic disease therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atopic disease therapeutics market Market Segmentation • Disease Type Insights (Revenue, USD Bn, 2021 - 2033) o Atopic Dermatitis o Allergic Rhinitis o Asthma o Food Allergies o Conjunctivitis o Others • Drug Class Insights (Revenue, USD Bn, 2021 - 2033) o Topical Steroids o Topical Calcineurin Inhibitors o Biologics (e.g., Monoclonal Antibodies, JAK Inhibitors) o Systemic Steroids o Immunosuppressants o Others • Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) o Topical o Oral o Injectable • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Dermatology Clinics o Homecare Settings o Pharmacies • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Online o Offline • Patient Type Insights (Revenue, USD Bn, 2021 - 2033) o Acute o Chronic • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Pfizer Inc o Sanofi o AbbVie Inc o Galderma Laboratories, L.P. o Eli Lilly and Company o Regeneron Pharmaceuticals Inc o LEO Pharma Inc o Otsuka Pharmaceutical Co., Ltd o Novartis AG o Incyte Corporation o Astellas Pharma Inc o Bayer AG o Allergan plc o Amgen Inc o GlaxoSmithKline plc

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Atopic Disease Therapeutics Market, By Disease Type  Global Atopic Disease Therapeutics Market, By Drug Class  Global Atopic Disease Therapeutics Market, By Route of Administration  Global Atopic Disease Therapeutics Market, By End User  Global Atopic Disease Therapeutics Market, By Distribution Channel  Global Atopic Disease Therapeutics Market, By Patient Type  Global Atopic Disease Therapeutics Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Atopic Disease Therapeutics Market, By Disease Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Atopic Dermatitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Allergic Rhinitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Asthma  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Food Allergies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Conjunctivitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Atopic Disease Therapeutics Market, By Drug Class, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Topical Steroids  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Topical Calcineurin Inhibitors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Biologics (e.g., Monoclonal Antibodies, JAK Inhibitors)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Systemic Steroids  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Immunosuppressants  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Atopic Disease Therapeutics Market, By Route of Administration, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Topical  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Injectable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Atopic Disease Therapeutics Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Dermatology Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Homecare Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Atopic Disease Therapeutics Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Online  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Offline  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Atopic Disease Therapeutics Market, By Patient Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Acute  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Chronic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 10. Global Atopic Disease Therapeutics Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Pfizer Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sanofi  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o AbbVie Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Galderma Laboratories, L.P.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Eli Lilly and Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Regeneron Pharmaceuticals Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o LEO Pharma Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Otsuka Pharmaceutical Co., Ltd  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Incyte Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Astellas Pharma Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bayer AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Allergan plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Amgen Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o GlaxoSmithKline plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Atopic Disease Therapeutics Market' - Global forecast to 2033

提及公司

Pfizer IncSanofiAbbVie IncGalderma Laboratories, L.P.Eli Lilly and CompanyRegeneron Pharmaceuticals IncLEO Pharma IncOtsuka Pharmaceutical Co., LtdNovartis AGIncyte CorporationAstellas Pharma IncBayer AGAllergan plcAmgen IncGlaxoSmithKline plc

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們